A Phase III, Observer Blind, Active Controlled, Randomized, Clinical Study Comparing Safety and Immunogenicity of BBio Bivalent Oral Polio Vaccine With a Licensed Bivalent Oral Polio Vaccine
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 17 Nov 2017
At a glance
- Drugs Poliovirus vaccine (Primary)
- Indications Poliomyelitis
- Focus Adverse reactions; Pharmacodynamics; Registrational
- Sponsors Bilthoven Biologicals
- 10 Nov 2017 Planned End Date changed from 1 Mar 2018 to 30 Mar 2018.
- 10 Nov 2017 Planned primary completion date changed from 1 Dec 2017 to 15 Feb 2018.
- 10 Nov 2017 Status changed from recruiting to active, no longer recruiting.